214 related articles for article (PubMed ID: 37797010)
21.
Bando H; Lee Y; Sakaguchi N; Pradipta A; Sakamoto R; Tanaka S; Ma JS; Sasai M; Yamamoto M
Front Cell Infect Microbiol; 2019; 9():140. PubMed ID: 31119110
[No Abstract] [Full Text] [Related]
22. Essential Role of mGBP7 for Survival of Toxoplasma gondii Infection.
Steffens N; Beuter-Gunia C; Kravets E; Reich A; Legewie L; Pfeffer K; Degrandi D
mBio; 2020 Jan; 11(1):. PubMed ID: 31964735
[TBL] [Abstract][Full Text] [Related]
23. Inducible Nitric Oxide Synthase Is a Key Host Factor for
Bando H; Lee Y; Sakaguchi N; Pradipta A; Ma JS; Tanaka S; Cai Y; Liu J; Shen J; Nishikawa Y; Sasai M; Yamamoto M
mBio; 2018 Oct; 9(5):. PubMed ID: 30301855
[TBL] [Abstract][Full Text] [Related]
24. A family of IFN-γ-inducible 65-kD GTPases protects against bacterial infection.
Kim BH; Shenoy AR; Kumar P; Das R; Tiwari S; MacMicking JD
Science; 2011 May; 332(6030):717-21. PubMed ID: 21551061
[TBL] [Abstract][Full Text] [Related]
25. Guanylate Binding Proteins Restrict Leishmania donovani Growth in Nonphagocytic Cells Independent of Parasitophorous Vacuolar Targeting.
Haldar AK; Nigam U; Yamamoto M; Coers J; Goyal N
mBio; 2020 Jul; 11(4):. PubMed ID: 32723921
[TBL] [Abstract][Full Text] [Related]
26. Cell-autonomous
Pradipta A; Sasai M; Motani K; Ma JS; Lee Y; Kosako H; Yamamoto M
Life Sci Alliance; 2021 Jul; 4(7):. PubMed ID: 34078740
[TBL] [Abstract][Full Text] [Related]
27. Host immune responses to Toxoplasma gondii.
Sasai M; Pradipta A; Yamamoto M
Int Immunol; 2018 Mar; 30(3):113-119. PubMed ID: 29408976
[TBL] [Abstract][Full Text] [Related]
28. Genetic Screen in Chlamydia muridarum Reveals Role for an Interferon-Induced Host Cell Death Program in Antimicrobial Inclusion Rupture.
Giebel AM; Hu S; Rajaram K; Finethy R; Toh E; Brothwell JA; Morrison SG; Suchland RJ; Stein BD; Coers J; Morrison RP; Nelson DE
mBio; 2019 Apr; 10(2):. PubMed ID: 30967464
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic Control of IFN-γ Host Responses During Infection With
Nast R; Choepak T; Lüder CGK
Front Immunol; 2020; 11():581241. PubMed ID: 33072127
[TBL] [Abstract][Full Text] [Related]
30. GTP is an allosteric modulator of the interaction between the guanylate-binding protein 1 and the prosurvival kinase PIM1.
Persico M; Petrella L; Orteca N; Di Dato A; Mariani M; Andreoli M; De Donato M; Scambia G; Novellino E; Ferlini C; Fattorusso C
Eur J Med Chem; 2015 Feb; 91():132-44. PubMed ID: 25081641
[TBL] [Abstract][Full Text] [Related]
31. Guanylate-Binding Protein 1, an Interferon-Induced GTPase, Exerts an Antiviral Activity against Classical Swine Fever Virus Depending on Its GTPase Activity.
Li LF; Yu J; Li Y; Wang J; Li S; Zhang L; Xia SL; Yang Q; Wang X; Yu S; Luo Y; Sun Y; Zhu Y; Munir M; Qiu HJ
J Virol; 2016 May; 90(9):4412-4426. PubMed ID: 26889038
[TBL] [Abstract][Full Text] [Related]
32. Human GBP1 does not localize to pathogen vacuoles but restricts Toxoplasma gondii.
Johnston AC; Piro A; Clough B; Siew M; Virreira Winter S; Coers J; Frickel EM
Cell Microbiol; 2016 Aug; 18(8):1056-64. PubMed ID: 26874079
[TBL] [Abstract][Full Text] [Related]
33. Guanylate-Binding Protein 1: An Emerging Target in Inflammation and Cancer.
Honkala AT; Tailor D; Malhotra SV
Front Immunol; 2019; 10():3139. PubMed ID: 32117203
[TBL] [Abstract][Full Text] [Related]
34. LPS-aggregating proteins GBP1 and GBP2 are each sufficient to enhance caspase-4 activation both in cellulo and in vitro.
Dickinson MS; Kutsch M; Sistemich L; Hernandez D; Piro AS; Needham D; Lesser CF; Herrmann C; Coers J
Proc Natl Acad Sci U S A; 2023 Apr; 120(15):e2216028120. PubMed ID: 37023136
[TBL] [Abstract][Full Text] [Related]
35. Messenger ribonucleic acid encoding interferon-inducible guanylate binding protein 1 is induced in human endometrium within the putative window of implantation.
Kumar S; Li Q; Dua A; Ying YK; Bagchi MK; Bagchi IC
J Clin Endocrinol Metab; 2001 Jun; 86(6):2420-7. PubMed ID: 11397834
[TBL] [Abstract][Full Text] [Related]
36. Mycobacterial Cord Factor Reprograms the Macrophage Response to IFN-γ towards Enhanced Inflammation yet Impaired Antigen Presentation and Expression of GBP1.
Huber A; Killy B; Grummel N; Bodendorfer B; Paul S; Wiesmann V; Naschberger E; Zimmer J; Wirtz S; Schleicher U; Vera J; Ekici AB; Dalpke A; Lang R
J Immunol; 2020 Sep; 205(6):1580-1592. PubMed ID: 32796022
[TBL] [Abstract][Full Text] [Related]
37. CD40 signaling in macrophages induces activity against an intracellular pathogen independently of gamma interferon and reactive nitrogen intermediates.
Andrade RM; Portillo JA; Wessendarp M; Subauste CS
Infect Immun; 2005 May; 73(5):3115-23. PubMed ID: 15845519
[TBL] [Abstract][Full Text] [Related]
38. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.
Yap GS; Sher A
J Exp Med; 1999 Apr; 189(7):1083-92. PubMed ID: 10190899
[TBL] [Abstract][Full Text] [Related]
39. The GBP1 microcapsule interferes with IcsA-dependent septin cage assembly around Shigella flexneri.
Kutsch M; González-Prieto C; Lesser CF; Coers J
Pathog Dis; 2021 Apr; 79(5):. PubMed ID: 33885766
[TBL] [Abstract][Full Text] [Related]
40. Human guanylate binding proteins: nanomachines orchestrating host defense.
Kutsch M; Coers J
FEBS J; 2021 Oct; 288(20):5826-5849. PubMed ID: 33314740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
